Drug intelligence / Profile preview

galloflavin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Galloflavin is a **small molecule inhibitor of lactate dehydrogenase (LDH)**, specifically targeting LDH isoforms A (LDH-A) and B (LDH-B)[3][5]. It acts **by inhibiting glycolysis and ATP production**, exerting anti-proliferative effects in various cancer cell lines including breast, colorectal, pancreatic, and endometrial cancer[1][2][5]. Galloflavin demonstrates anticancer activity by blocking cell proliferation, migration, and invasion, reducing colony formation, and suppressing the expression of tumor-related proteins such as c-Myc and P21[1]. In inflammatory microenvironments, galloflavin also **directly targets and inhibits NLRP3**, an inflammasome component involved in cancer progression, reducing the expression of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β), and tumor growth in animal models[1].

Other names
galloflavin GF
02

Targets

LDH (L-lactate dehydrogenase A chain)

Beyond the preview

Go deeper on galloflavin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on galloflavin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call